Home » Authors » Nuala Moran

Articles by Nuala Moran

Arrow Spins Out Immunoprime To Focus On Infectious Disease

Jan. 5, 2005

GW Rebounds From UK Denial With Sativex Canadian Approval

Dec. 29, 2004

Pharmagene Shares Fall On Failed Phase IIa Study, Lower Guidance

Dec. 29, 2004

LONDON - Shares in Pharmagene plc dropped by one-quarter when the company announced its lead product, PGN0052, failed in a Phase IIa trial in cystic fibrosis and the company warned that 2004 revenues from its drug discovery services would be lower than 2003. (BioWorld International)

Pharmagene Shares Fall On Failed Phase IIa Study, Lower Guidance

Dec. 29, 2004

LONDON - Shares in Pharmagene plc dropped by one-quarter when the company announced its lead product, PGN0052, failed in a Phase IIa trial in cystic fibrosis and the company warned that 2004 revenues from its drug discovery services would be lower than 2003. (BioWorld International)

GW Rebounds From UK Denial With Sativex Canadian Approval

Dec. 29, 2004

CAT Wins Court Battle Over Humira; Abbott Logs Appeal

Dec. 22, 2004

CAT Wins Court Battle Over Humira; Abbott Logs Appeal

Dec. 22, 2004

Phytopharm Product, Not Good For Pharma, Aimed At Foods

Dec. 22, 2004

CAT Wins Court Battle Over Humira; Abbott Logs Appeal

Dec. 22, 2004

Phytopharm Product, Not Good For Pharma, Aimed At Foods

Dec. 22, 2004

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...